Hybrid lymphoblastoid-leukocyte human interferons
US4716217A · kind A · utility
12Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 1984 |
| Grant date | Dec 29, 1987 |
| Priority date | — |
| Expiry date | Aug 31, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/142
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
DNA sequences encoding for novel human lymphoblastoid-leukocyte hybrid interferons. Methods of making nucleotide sequences comprising ribosome binding sites, promoter regions, and segments of human lymphoblastoid and leukocyte interferons are described. DNA sequences for hybrid interferons are cloned and expressed in plasmid vectors. Transformed microorganisms and novel lymphoblastoid-leukocyte polypeptide interferons having biological or immunological activity are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.